Covaxin is among the leading vaccine candidates against the novel coronavirus, which causes COVID-19. Development and subsequent approval of a vaccine is key in ending the COVID-19 pandemic which has led to over 5.5 crore confirmed infections across the world. The global death toll due to the outbreak stands at 13.3 lakh. … [Read more...] about Coronavirus vaccine update: Haryana Health Minister Anil Vij offers to volunteer for Covaxin trial
The company said it submitted all documentation within timelines, and as mandated by the ethics committees and CDSCO, including a complete causality report, and got an approval for the next two phases of clinical trials only after a detailed investigation of the incident was completed, LiveMint reported. … [Read more...] about COVID-19 Vaccine | Bharat Biotech’s Covaxin reported adverse event during Phase 1 trials, trials not halted
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine. … [Read more...] about COVID-19 vaccine update: Phase 3 trial of Covaxin begins at AIIMS Delhi; 15,000 to be inoculated
Bharat Biotech said the adverse event during Phase I clinical trials in August was promptly to the CDSCO-DCGI within 24 hours of its occurrence and confirmation. The company said they investigated the adverse even and determined it as not vaccine related. But we still don't have information such as whether the participant who had adverse event is part of control group (received placebo) or vaccine group. If the participant is from control group, than it wouldn't of big concern. … [Read more...] about Moderna, Pfizer and AstraZeneca: What is the latest on COVID-19 vaccine from the manufacturers?
President of Quality Operations at Bharat Biotech Sai D Prasad told CNN-News18 that the World Health Organisation (WHO), United States Food and Drug Administration (USFDA), and India's Central Drugs Standard Control Organisation (CDSCO) approved a respiratory disease vaccine if it was at least 50 percent effective. … [Read more...] about Bharat Biotech says its COVID-19 vaccine will have 60% efficacy